Cargando…

Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period

(1) Purpose: To retrospectively assess the technical and clinical outcome of patients with symptomatic postoperative fluid collections after pancreatic surgery, treated with CT-guided drainage (CTD). (2) Methods: 133 eligible patients between 2004 and 2017 were included. We defined technical success...

Descripción completa

Detalles Bibliográficos
Autores principales: Trumm, Christoph G., Hackner, Danilo, Badmann, Katharina, Crispin, Alexander, Forbrig, Robert, Ozpeynirci, Yigit, Kuppinger, David, Pedersen, Vera, Liebig, Thomas, Stahl, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498101/
https://www.ncbi.nlm.nih.gov/pubmed/36140644
http://dx.doi.org/10.3390/diagnostics12092243
_version_ 1784794673179525120
author Trumm, Christoph G.
Hackner, Danilo
Badmann, Katharina
Crispin, Alexander
Forbrig, Robert
Ozpeynirci, Yigit
Kuppinger, David
Pedersen, Vera
Liebig, Thomas
Stahl, Robert
author_facet Trumm, Christoph G.
Hackner, Danilo
Badmann, Katharina
Crispin, Alexander
Forbrig, Robert
Ozpeynirci, Yigit
Kuppinger, David
Pedersen, Vera
Liebig, Thomas
Stahl, Robert
author_sort Trumm, Christoph G.
collection PubMed
description (1) Purpose: To retrospectively assess the technical and clinical outcome of patients with symptomatic postoperative fluid collections after pancreatic surgery, treated with CT-guided drainage (CTD). (2) Methods: 133 eligible patients between 2004 and 2017 were included. We defined technical success as the sufficient drainage of the fluid collection(s) and the absence of peri-interventional complications (minor or major according to SIR criteria). Per definition, clinical success was characterized by normalization of specific blood parameters within 30 days after the intervention or a decrease by at least 50% without requiring additional surgical revision. C-reactive protein (CRP), Leukocytes, Interleukin-6, and Dose length product (DLP) for parts of the intervention were determined. (3) Results: 97.0% of 167 interventions were technically successful. Clinical success was achieved in 87.5% of CRP, in 78.4% of Leukocytes, and in 87.5% of Interleukin-6 assessments. The median of successful decrease was 6 days for CRP, 5 days for Leukocytes, and 2 days for Interleukin-6. No surgical revision was necessary in 93.2%. DLP was significantly lower in the second half of the observation period (total DLP: median 621.5 mGy*cm between 2011–2017 vs. median 944.5 mGy*cm between 2004–2010). (4) Conclusions: Technical success rate of CTD was very high and the clinical success rate was fair to good. Given an elderly and multimorbid patient cohort, CTD can have a temporizing effect in the postoperative period after pancreatic surgery. Reducing the radiation dose over time might reflect developments in CT technology and increased experience of interventional radiologists.
format Online
Article
Text
id pubmed-9498101
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94981012022-09-23 Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period Trumm, Christoph G. Hackner, Danilo Badmann, Katharina Crispin, Alexander Forbrig, Robert Ozpeynirci, Yigit Kuppinger, David Pedersen, Vera Liebig, Thomas Stahl, Robert Diagnostics (Basel) Article (1) Purpose: To retrospectively assess the technical and clinical outcome of patients with symptomatic postoperative fluid collections after pancreatic surgery, treated with CT-guided drainage (CTD). (2) Methods: 133 eligible patients between 2004 and 2017 were included. We defined technical success as the sufficient drainage of the fluid collection(s) and the absence of peri-interventional complications (minor or major according to SIR criteria). Per definition, clinical success was characterized by normalization of specific blood parameters within 30 days after the intervention or a decrease by at least 50% without requiring additional surgical revision. C-reactive protein (CRP), Leukocytes, Interleukin-6, and Dose length product (DLP) for parts of the intervention were determined. (3) Results: 97.0% of 167 interventions were technically successful. Clinical success was achieved in 87.5% of CRP, in 78.4% of Leukocytes, and in 87.5% of Interleukin-6 assessments. The median of successful decrease was 6 days for CRP, 5 days for Leukocytes, and 2 days for Interleukin-6. No surgical revision was necessary in 93.2%. DLP was significantly lower in the second half of the observation period (total DLP: median 621.5 mGy*cm between 2011–2017 vs. median 944.5 mGy*cm between 2004–2010). (4) Conclusions: Technical success rate of CTD was very high and the clinical success rate was fair to good. Given an elderly and multimorbid patient cohort, CTD can have a temporizing effect in the postoperative period after pancreatic surgery. Reducing the radiation dose over time might reflect developments in CT technology and increased experience of interventional radiologists. MDPI 2022-09-16 /pmc/articles/PMC9498101/ /pubmed/36140644 http://dx.doi.org/10.3390/diagnostics12092243 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Trumm, Christoph G.
Hackner, Danilo
Badmann, Katharina
Crispin, Alexander
Forbrig, Robert
Ozpeynirci, Yigit
Kuppinger, David
Pedersen, Vera
Liebig, Thomas
Stahl, Robert
Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period
title Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period
title_full Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period
title_fullStr Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period
title_full_unstemmed Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period
title_short Low-Milliampere CT Fluoroscopy-Guided Percutaneous Drainage Placement after Pancreatic Surgery: Technical and Clinical Outcome in 133 Consecutive Patients during a 14-Year Period
title_sort low-milliampere ct fluoroscopy-guided percutaneous drainage placement after pancreatic surgery: technical and clinical outcome in 133 consecutive patients during a 14-year period
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498101/
https://www.ncbi.nlm.nih.gov/pubmed/36140644
http://dx.doi.org/10.3390/diagnostics12092243
work_keys_str_mv AT trummchristophg lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod
AT hacknerdanilo lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod
AT badmannkatharina lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod
AT crispinalexander lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod
AT forbrigrobert lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod
AT ozpeynirciyigit lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod
AT kuppingerdavid lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod
AT pedersenvera lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod
AT liebigthomas lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod
AT stahlrobert lowmilliamperectfluoroscopyguidedpercutaneousdrainageplacementafterpancreaticsurgerytechnicalandclinicaloutcomein133consecutivepatientsduringa14yearperiod